The paper is from theThe Fatty Acids and Outcomes Research Consortium (FORCE), comprised of researchers from around the world who have gathered data on blood fatty acid levels in large groups of study subjects and followed those individuals for years to determine what diseases they develop. The current study focused on omega-3 levels and the risk for death during the follow-up period, and thanks to data pooled from the consortium's researchers, it is the largest study yet to do so, FARI reported.
The new report is a prospective analysis of pooled data from 17 separate cohorts from around the world, including 42,466 people followed for 16 years on average. During that time, 15,720 of the people died. Analysis revealed that those who had the highest EPA+DHA levels (i.e., at the 90th percentile) had a statistically significant, 13% lower risk for death than people with EPA+DHA levels in the 10th percentile. The researchers looked at three major causes of death and found statistically significant risk reductions (comparing the 90th vs 10th percentile):
- Cardiovascular disease: 15% risk reduction
- Cancer: 11% risk reduction
- All other causes combined: 13% risk reduction
Tom Brenna, PhD, Professor of Pediatrics, Human Nutrition, and Chemistry, Dell Medical School of the University of Texas at Austin, added: “This comprehensive look at observational studies of circulating omega-3 fatty acids indicates that the long chain omega-3s EPA, DPA, and DHA, usually obtained from seafood, are strongly associated with all-cause mortality, while levels of the plant omega-3 alpha-linolenic acid (ALA) are less so."